LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve Consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year Ended on March 31, 2019, Recommendation of Dividend on Equity Shares of the Company for the Financial Year Ended on March 31, 2019, if any and Any other matter with the approval of the chair.
Source : BSE - www.bseindia.com
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.